However, BET bromodomain inhibitors mainly induce cell-cycle arrest, but not apoptosis in ovarian cancer cells, which is likely a potential obstacle of their application in treating ovarian cancer patients. The gene discussed is DNER; the disease is ovarian carcinoma.